School of Medicine
Showing 7,561-7,580 of 13,016 Results
-
Christina Milcarek
Executive Administrator, Med/Stanford Center for Clinical Research
Current Role at StanfordProviding executive support to:
Dr. Kenneth Mahaffey, Founding Director, Stanford Center for Clinical Research (SCCR) -
Amin Milki, M.D.
Professor of Obstetrics and Gynecology (Reproductive Endocrinology and Infertility)
Current Research and Scholarly InterestsInfertility
Assisted Reproductive Technologies Microsurgery and Endoscopic Surgery. -
Carlos Milla
Professor of Pediatrics (Pulmonary Medicine) and, by courtesy, of Medicine (Pulmonary, Allergy and Critical Care Medicine)
Current Research and Scholarly InterestsAt Stanford University I developed and currently direct the CF Translational Research Center. The overarching goal of the center is to provide the groundwork to streamline, accelerate, and promote the translation of basic discoveries into effective therapies and interventions to benefit patients affected by cystic fibrosis. My laboratory group currently has three main lines of investigation: respiratory cell biology in CF; remote biochemical monitoring; and lung physiology in young children.
-
Robert S. Millard, MD
Clinical Associate Professor, Orthopaedic Surgery
BioDr. Robert Millard is board certified in Physical Medicine and Rehabilitation. He Is fellowship trained in Interventional spine care and Sports Medicine. Prior to joining Stanford, he was in private practice for 27 years. Dr. Millard’s medical practice involves the treatment of spine pain syndromes and Sports injuries. Interventional spine procedures performed by Dr. Millard include cervical/lumbar: transforaminal epidural injections; facet injections; medial branch blocks and radio frequency ablation (rhizotomies). He has served as team physician for the San Francisco 49ers (1992-2008) and the San Jose Sharks (2005-2015).
-
D. Craig Miller, M.D.
Thelma and Henry Doelger Professor of Cardiovascular Surgery, Emeritus
Current Research and Scholarly InterestsCardiac and heart valve disease with experimental laboratory large animal projects focused on the investigation of left ventricular and cardiac mechanics, bioenergetics, and LV and mitral valve physiology and pathophysiology. Current thrust is aimed at understanding the mitral valve and subvalvular mitral apparatus and transmural LV wall strains, thickening, and myolaminar fiber-sheet mechanics.
Clinical research interests include thoracic aortic diseases (aortic dissection, aneurysm) and cardiac valvular disease, including surgical treatment, endovascular thoracic aortic stent-graft repair, mitral valve repair, and valve-sparing aortic root replacement. -
Jessica Tran Miller
Clinical Assistant Professor, Medicine
BioDr. Jessica Tran Miller is a Clinical Assistant Professor of Medicine and hospitalist at Stanford. She serves as Associate Director of Quality for the Division of Hospital Medicine, as well as Unit-Based Medical Director for the Alternative Inpatient Care Areas. She is also a physician lead for Stanford Health Care at Home, where she helped expand surgical post-acute care pathways.
Dr. Miller’s research focuses on the application and evaluation of artificial intelligence in clinical care, including personalized patient education, care transitions, and the clinical quality and safety of large language model-generated responses. She leads funded research investigating how AI-personalized education can improve continuity of care following hospitalization. Her work has been published in the Annals of Internal Medicine and presented at national and international forums.
A graduate of Stanford Medicine's Realizing Improvement through Team Empowerment program, Dr. Miller is active in quality improvement leadership within the Division of Hospital Medicine, with interests spanning care transitions, high-value care, and care delivery innovation. She also serves as a faculty advisor and instructor for the Stanford Healthcare Consulting Group, mentoring undergraduate, medical, and business students as they develop initiatives to address real-world health care delivery challenges.
